Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest FY Q1 profit tops expectations; sales rise
Reuters
Tuesday, July 19, 2011 - 6:17pm
tags:
earnings, Forest Labs
Dynavax Technologies: Heplisav Trial Results to Be Big Catalyst for Stock
Seeking Alpha
Tuesday, July 19, 2011 - 6:13pm
tags:
Heplisav, Dynavax, vaccines, hepatitis B
Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tuesday, July 19, 2011 - 6:11pm
tags:
FDA, AstraZeneca, diabetes, Bristol-Myers Squibb, Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tuesday, July 19, 2011 - 1:14pm
tags:
AstraZeneca, FDA, Brilinta, blood thinners, Dapagliflozin, Bristol-Myers Squibb
Study finds two antidepressants ineffective for dementia patients
Reuters
Tuesday, July 19, 2011 - 1:02pm
tags:
antidepressants, dementia, Pfizer, Zoloft, Remeron, Alzheimer's disease
FDA Is Urged To Suspend Trials Of Novartis Drug
Pharmalot
Tuesday, July 19, 2011 - 1:01pm
tags:
FDA, Novartis, Ilaris, Public Citizen
Hemispherx gets patent for Ampligen as flu vaccine enhancer
Bizjournals.com
Tuesday, July 19, 2011 - 12:29pm
tags:
Hemispherx, Ampligen, Flu, vaccines
Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests
Bloomberg
Tuesday, July 19, 2011 - 12:22pm
tags:
AIDS, HIV, GSK, Pfizer, Bristol-Myers Squibb, Dolutegravir, Sustiva, ViiV Healthcare
Do pharma BOD rosters clash with biotech strategy?
Fierce Biotech
Tuesday, July 19, 2011 - 12:20pm
tags:
biotech, R&D
FDA pushes new heart warning on AZ's Seroquel
Fierce Pharma
Tuesday, July 19, 2011 - 12:19pm
tags:
AstraZeneca, Seroquel, FDA, warnings, antipsychotics
Mannkind and BioMimetic Suffer From Poor Management
Seeking Alpha
Tuesday, July 19, 2011 - 12:13pm
tags:
MannKind, BioMimetic Therapeutics
Immunocellular Therapeutics: An Interesting Biotech
Seeking Alpha
Tuesday, July 19, 2011 - 12:12pm
tags:
ImmunoCellular Therapeutics, cancer, Bristol-Myers Squibb, Dendreon, Oncothyreon
Medicis shares tumble again
Bizjournals.com
Tuesday, July 19, 2011 - 12:11pm
tags:
Medicis, Jonah Shacknai
Allergan to buy Vicept, developer of experimental rosacea treatment
Bizjournals.com
Tuesday, July 19, 2011 - 12:09pm
tags:
Allergan, Vicept, Rosacea, M&A
J&J Slips After Earnings Despite Beat; Is Guidance Conservative?
Barron's
Tuesday, July 19, 2011 - 11:55am
tags:
earnings, guidance, JNJ
Dawn of A New Sleep Drug?
WSJ Online
Tuesday, July 19, 2011 - 11:54am
tags:
insomnia, GSK, Actelion, Sanofi
Pozen brings in digital advisers
Bizjournals.com
Tuesday, July 19, 2011 - 11:19am
tags:
Pozen, digital pharma
Lilly Says Alzheimer Patients Didn’t Improve
Bloomberg
Tuesday, July 19, 2011 - 11:00am
tags:
Alzheimer's disease, semagacestat
J&J’s Profit Beats Analysts’ Estimates on Prostate Cancer, Psoriasis Drugs
Bloomberg
Tuesday, July 19, 2011 - 10:23am
tags:
earnings, JNJ
Earnings Preview: Eli Lilly reports on 2Q Thursday
Yahoo/AP
Tuesday, July 19, 2011 - 10:22am
tags:
earnings, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.